The Interventional Oncology Center

Filter Your Results




BTG's DC Bead Lumi Receives CE Mark Certification

March 13, 2017 -- BTG plc announced that it has received Class III CE Mark certification for European commercialization of the company's next-generation DC Bead Lumi. The …

Surefire Medical's Infusion Technology Studied for Treatment of Primary Liver Cancer

March 8, 2017 -- Surefire Medical, Inc. announced that clinical data from a retrospective case-controlled comparison showed that the use of Surefire infusion technology achiev…

Medtronic’s OsteoCool System Granted Expanded Indication by FDA for the Palliative Treatment of Metastatic Bone Tumors

February 15, 2017 -- Medtronic announced that the US Food and Drug Administration has approved an expanded indication for its OsteoCool RF Ablation System for the palliat…

NCCN Guidelines Recommend SIR-Spheres Y-90 Resin Microspheres to Treat Metastatic Colorectal Cancer

December 12, 2016 -- Sirtex Medical Limited announced that the company's SIR-Spheres yttrium-90 (Y-90) resin microspheres have been included as a category 2A recommended t…

Surefire Medical Receives Grant for Clinical Trial Investigating CAR-T Therapy Delivery Using Precision Infusion System

November 15, 2016 -- Surefire Medical, Inc. has announced that it has received a grant from the Colorado Office of Economic Development and International Trade to commence&nbs…

BTG and Mirada Medical’s Simplicit90Y Dosimetry Software Approved in Europe

October 14, 2016 -- BTG plc and Mirada Medical Ltd. announced European CE Mark certification for Simplicit90Y yttrium-90 (Y-90) dosimetry software. The software is designed to…

Meta-Analysis of Trials Comparing Radioembolization and Chemoembolization for Unresectable HCC Published

October 13, 2016 -- Findings from a systematic review and meta-analysis comparing clinical outcomes of transarterial radioembolization (TARE) versus transarterial chemoemboliz…

Sirtex Microspheres to Be Studied for Cholangiocarcinoma in SIRCCA and Included in ESMO Guidelines

October 11, 2016 -- Sirtex Medical Ltd announced the commencement of SIRCCA (Selective Internal Radiation Therapy [SIRT] in Cholangiocarcinoma), a phase 2 study of the co…



2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.